The debate over Florida’s HIV medication cuts is intensifying as advocates, lawmakers, and healthcare professionals push back ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Advocates and patients warn thousands of Floridians living with HIV could lose access to life-saving medications under ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

Although adolescents and young adults comprise only one quarter of the sexually active population in the United States, ...

Until last year, the number of children orphaned because a parent died from AIDS, was plummeting. That's thanks to America's 20 year effort to get lifesaving HIV meds to millions in need. But last ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

Activities staff member Robert Hardrick teaches chair tai chi for residents of Broadway House for Continuing Care in New Jersey. (Photo: Courtesy of Broadway House) Nursing home patients with HIV may ...

The National Alliance of State and Territorial AIDS Directors estimates more than 16,000 Floridians will lose coverage.

An estimated 10,000 people are about to lose access to their HIV medication as the Florida Department of Health makes cuts to ...